Pharmabiz21h
Third meeting of the International Health Regulations (2005) Emergency Committee regarding the upsurge of mpox 2024 – Temporary recommendations
Third meeting of the International Health Regulations (2005) Emergency Committee regarding the upsurge of mpox 2024 – Temporary recommendations ...
Pharmabiz18h
US FDA approves first human milk-based fortifier for infants to support growth and recovery following surgery for gastroschisis
US FDA approves first human milk-based fortifier for infants to support growth and recovery following surgery for gastroschisis: Duarte, California Saturday, March 1, 2025, 16:00 ...
Pharmabiz16h
ProMIS Neurosciences begins patient dosing in phase 1b PRECISE-AD trial of PMN310 for Alzheimer’s disease
Massachusetts, Cambridge Saturday, March 1, 2025, 18:00 Hrs [IST] ...
Pharmabiz20h
Kangpu Biopharma receives China NMPA’s IND approval for KPG-818 to treat relapsed/refractory multiple myeloma
Kangpu Biopharma receives China NMPA’s IND approval for KPG-818 to treat relapsed/refractory multiple myeloma: Hefei, China Saturday, March 1, 2025, 14:00 Hrs [IST] Kangpu Bioph ...
Pharmabiz17h
ImmunityBio receives US FDA’s regenerative medicine advanced therapy designation for Anktiva and CAR-NK for metastatic pancreatic cancer
Culver City, California Saturday, March 1, 2025, 17:00 Hrs [IST] ...
Pharmabiz23h
Medigene & EpimAb ink co-development partnership for TCR-guided T Cell Engagers to treat of immune-related disorders
Medigene & EpimAb ink co-development partnership for TCR-guided T Cell Engagers to treat of immune-related disorders: Planegg, Martinsried Saturday, March 1, 2025, 11:00 Hrs [IST] ...
Pharmabiz22h
Akeso begins patient enrolment in phase I trial of AK138 D1 for the treatment of advanced malignancies in Australia
Akeso begins patient enrolment in phase I trial of AK138 D1 for the treatment of advanced malignancies in Australia: Hong Kong Saturday, March 1, 2025, 12:00 Hrs [IST] Akeso, Inc.
Pharmabiz19h
MYndspan & MEGIN partner to make magnetoencephalography brain scans more accessible
MYndspan & MEGIN partner to make magnetoencephalography brain scans more accessible: London Saturday, March 1, 2025, 15:00 Hrs [IST] MYndspan, a pioneer in consumer brain health t ...